Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 2016

View Archived Issues

Phase II results demonstrate safety and efficacy of new drug for Wilson's disease

Oyi-based therapeutic HIV vaccine reduces the HIV RNA rebound median following cART interruption

TGI and Quark enter discovery and development collaboration

Zavante starts ZEUS trial for ZTI-01 in cUTI patients

KU Leuven and Ortho-McNeil-Janssen Pharmaceuticals patent dengue viral replication inhibitors

Oncolytics reports results on Reolysin phase II study

Akari and XL-protein to develop longer-acting version of Coversin

Synta Pharmaceuticals and Madrigal Pharmaceuticals announce merger agreement

RespiVert and Topivert Pharma disclose MAPK14, Src and Syk inhibitors

Redx Pharma develops IDO1 and/or TDO2 inhibitors

XuanZhu Pharma describes ALK and MCF3 inhibitors

Merrimack and Leica partner to develop companion diagnostic assays

PI3K inhibitors revealed in XuanZhu Pharma patent

Presage extends alliance with Takeda to provide access to CIVO platform

Burzynski Research Institute initiates phase II trial in diffuse intrinsic brainstem glioma

GeoVax receives SBIR grant for clade B HIV vaccine

TGen announces two new combination trials in pancreatic cancer

FDA acepts sBLA for Opdivo in patients with classical Hodgkin lymphoma

PsiOxus and Parker Institute collaborate on T-sign cancer platform

USAID launches Combating Zika and Future Threats: A Grand Challenge for Development

Phase I/IIa study investigates topically applied bisphosphocin Nu-3 for diabetic ulcers

FBRI and Meiji Seika collaborate on autoimmune and cancer drug research

Promising HCV T-cell vaccine HCV-003 to advance to phase II trials

Novel mutation in USMG5 gene may cause Leigh syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...